Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Introduction: The objective of this study was to retrospectively evaluate the ability of an artificial neural network (ANN) to predict bladder cancer recurrence and stage progression in patients with Ta/Tl bladder cancer, and 12 month cancer-specific survival, in a group of patients with T2-T4 bladder cancer. Patients and methods: Data were extracted from a database and analysed using a NeuralWorks Professional IIIPlus software package using the radial basis function algorithm. The input neural data for the prediction of stage progression in Ta/Tl bladder cancers (n = 105) included tumour stage, grade, size, multiplicity, male/female and epidermal growth factor receptor status. For the prediction of tumour recurrence within 6 months for Ta/Tl tumours (n= 56) and 12 month cancer-specific survival for T2T4 tumours (n = 40), additional neural inputs were; smoking habit, histology of mucosal biopsies, presence of carcinoma in situ, tumour metaplasia, tumour architecture/site, c-erbB-2 and p53 status. The network was trained on randomly selected patients and validated on the remaining exemplars. Results: The ANN analysis of the data gave (%); Sensitivity Specificity Accuracy Stage progression (Ta/T1) 70 82 80 Recurrence within 70 80 75 6 months (Ta/T1) 12 month cancer-specific 100 80 82 survival (T2-T4) When restricting the testing subset to patients with T1G3 tumours in relation to stage progression, the sensitivity of the ANN analysis ncreased to 100%. with a specificity of 78% and an accuracy of 82%. Conclusions: ANNs have been shown to be a useful adjunct in predicting outcomes in patients with bladder cancer. © 1998 British Journal of Urology.


Journal article


British Journal of Urology

Publication Date





24 - 25